Compare GOCO & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GOCO | SRTS |
|---|---|---|
| Founded | 2001 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.3M | 67.5M |
| IPO Year | 2020 | 2016 |
| Metric | GOCO | SRTS |
|---|---|---|
| Price | $2.50 | $3.84 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $5.00 | ★ $8.00 |
| AVG Volume (30 Days) | 40.3K | ★ 70.4K |
| Earning Date | 11-13-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $738,338,000.00 | $35,609,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $27.75 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.56 | N/A |
| 52 Week Low | $2.17 | $3.03 |
| 52 Week High | $21.00 | $9.08 |
| Indicator | GOCO | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 34.15 | 45.26 |
| Support Level | $2.80 | $3.56 |
| Resistance Level | $3.41 | $4.05 |
| Average True Range (ATR) | 0.21 | 0.18 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 1.08 | 25.30 |
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.